A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients

Edward Anthony Faber; Fausto R. Loberiza; Mojtaba Akhtari; Philip Bierman; R. Gregory Bociek; Lori Maness; Julie M Vose

A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients

Edward Anthony Faber, Fausto R. Loberiza, Mojtaba Akhtari, Philip Bierman, R. Gregory Bociek, Lori Maness, Julie M Vose

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	118
State	Published - Nov 18 2011

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

OpenUrl availability

Full text

Cite this

@article{994a5916feae44afbcea45edbafd24c2,

title = "A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients",

author = "Faber, {Edward Anthony} and Loberiza, {Fausto R.} and Mojtaba Akhtari and Philip Bierman and Bociek, {R. Gregory} and Lori Maness and Vose, {Julie M}",

note = "Consolidative high dose chemotherapy [HDT] and autologous peripheral blood hematopoietic stem cell transplant [auto-HSCT] is an effective treatment modality for multiple myeloma [MM]. Many advances during the last two decades have lead to significantly improved progression free survival [PFS] and overall survival [OS].",

year = "2011",

month = nov,

day = "18",

language = "American English",

volume = "118",

journal = "Blood",

}

TY - JOUR

T1 - A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients

AU - Faber, Edward Anthony

AU - Loberiza, Fausto R.

AU - Akhtari, Mojtaba

AU - Bierman, Philip

AU - Bociek, R. Gregory

AU - Maness, Lori

AU - Vose, Julie M

N1 - Consolidative high dose chemotherapy [HDT] and autologous peripheral blood hematopoietic stem cell transplant [auto-HSCT] is an effective treatment modality for multiple myeloma [MM]. Many advances during the last two decades have lead to significantly improved progression free survival [PFS] and overall survival [OS].

PY - 2011/11/18

Y1 - 2011/11/18

UR - http://www.bloodjournal.org/content/118/21/2040?sso-checked=true

M3 - Article

VL - 118

JO - Blood

JF - Blood

ER -

A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients

Disciplines

OpenUrl availability

Other files and links

Cite this